{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK6506/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK6506","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","market":"SI","secType":"PLATE","nameCN":"Pharmaceuticals & Medical Research","latestPrice":1.5665148e-7,"timestamp":1770704760133,"preClose":1.560111e-7,"halted":0,"volume":16220100,"delay":0,"changeRate":0.004105,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"02-10 14:29:57 SGT","open":1.5604564e-7,"high":1.5772981e-7,"low":1.5604564e-7,"amount":4714164.1,"amplitude":0.010795,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770714960000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1770683400000,1770696000000],[1770699600000,1770714960000]],"pbRate":1.689894,"peRate":10.882047,"turnoverRate":0.013583,"increases":2,"decrements":0,"flats":5,"marketCap":6718933352,"floatMarketCap":3933776827.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","high":1.5772981e-7,"amplitude":0.010795,"preClose":1.560111e-7,"low":1.5604564e-7,"pbRate":"1.689894","latestPrice":1.5665148e-7,"volume":16220100,"delay":0,"open":1.5604564e-7,"prevYearClose":1.4808467e-7,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0,"secType":"PLATE","market":"SI","turnoverRate":0.013583,"peRate":10.882047,"marketCap":6718933352,"floatMarketCap":3933776827.625,"timestamp":1770704760133,"nameCN":"Pharmaceuticals & Medical Research"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK6506\",,,,undefined,":{"bkCode":"BK6506","up":2,"down":0,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK6506\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609559180","title":"Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609559180","media":"MT Newswires","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609559180?lang=en_us&edition=fundamental","pubTime":"2026-02-06 14:17","pubTimestamp":1770358637,"startTime":"0","endTime":"0","summary":"JinYao Global, a subsidiary of Tianjin Pharmaceutical Da Ren Tang's  controlling shareholder, Tianjin Pharmaceutical, acquired additional S-Shares in the company at $2.96 apiece for $242,953, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical company were up over 3% in Friday trading.JinYao acquired 82,200 S-shares, representing around 0.0107% of the company's issued share capital. Following the acquisition of the new shares, the controlling shareholder's stake has increased to 43.008%.Meanwhile, JinYao Global has proposed to increase the shareholding further within six months, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6079","T14.SI","BK6506"],"gpt_icon":0},{"id":"2606567798","title":"Lonza's Attributable Profit Rises in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2606567798","media":"MT Newswires","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606567798?lang=en_us&edition=fundamental","pubTime":"2026-01-28 15:28","pubTimestamp":1769585333,"startTime":"0","endTime":"0","summary":"Lonza's  attributable profit to equity holders for 2025 jumped to 949 million Swiss francs from 636 million francs a year earlier, according to a Wednesday filing with the Singapore Exchange.Earnings per share of the pharmaceutical firm rose to 13.51 francs from 8.49 francs a year earlier.Sales jumped 19% year over year to 6.53 billion francs from 5.48 billion francs.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["O6Z.SI","BK6506"],"gpt_icon":0},{"id":"2606376832","title":"Haw Par Corporation Limited's (SGX:H02) top owners are retail investors with 37% stake, while 36% is held by private companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2606376832","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606376832?lang=en_us&edition=fundamental","pubTime":"2026-01-28 06:00","pubTimestamp":1769551255,"startTime":"0","endTime":"0","summary":"Key Insights Significant control over Haw Par by retail investors implies that the general public has more power to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/haw-par-corporation-limiteds-sgxh02-top-owners-are-retail-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/haw-par-corporation-limiteds-sgxh02-top-owners-are-retail-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["H02.SI","IE0031814969.USD","BK6506","SG9999006266.SGD","BK6079"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}